[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Sulfonamides Market Growth (Status and Outlook) 2023-2029

March 2023 | 85 pages | ID: G31A6E195F4EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Sulfonamides (sulphonamides) is a man-made group of medicines that includes the sulfonamide chemical group. Which is also called sulfa drugs. Sulfonamide antimicrobials are bacteriostatic (helps to stop generating new bacteria, but don’t surely kill them) and also work by intervening with the fusion of folic acid in bacteria, which is important for the formation of nucleic acid and ultimately for DNA and RNA. Sulfonamides are generally used in the pharmaceutical industry at a high rate. Where it is used as bacteriostatic agents which helps to kill the bacteria from human as well as from the animal’s body. Sulfonamides can be prepared in many ways in the laboratory. Sulfonamides are generally used for diabetes, fluid retention, high blood pressure, crohn’s disease, etc.

LPI (LP Information)' newest research report, the “Sulfonamides Industry Forecast” looks at past sales and reviews total world Sulfonamides sales in 2022, providing a comprehensive analysis by region and market sector of projected Sulfonamides sales for 2023 through 2029. With Sulfonamides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sulfonamides industry.

This Insight Report provides a comprehensive analysis of the global Sulfonamides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sulfonamides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sulfonamides market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sulfonamides and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sulfonamides.

The global Sulfonamides market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Sulfonamides is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Sulfonamides is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Sulfonamides is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Sulfonamides players cover Pfizer, Sanofi, Roche, Mylan, Teva, Bayer, Abbott, GlaxoSmithKline and Boehringer Ingelheim, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Sulfonamides market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Intestinal Absorption
  • Intestinal Tract Difficult to Absorb
  • External Use
Segmentation by application
  • Systemic Infection
  • Intestinal Infection
  • Burn Infection
  • Other Infections
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Pfizer
  • Sanofi
  • Roche
  • Mylan
  • Teva
  • Bayer
  • Abbott
  • GlaxoSmithKline
  • Boehringer Ingelheim
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Sulfonamides Market Size 2018-2029
  2.1.2 Sulfonamides Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Sulfonamides Segment by Type
  2.2.1 Intestinal Absorption
  2.2.2 Intestinal Tract Difficult to Absorb
  2.2.3 External Use
2.3 Sulfonamides Market Size by Type
  2.3.1 Sulfonamides Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Sulfonamides Market Size Market Share by Type (2018-2023)
2.4 Sulfonamides Segment by Application
  2.4.1 Systemic Infection
  2.4.2 Intestinal Infection
  2.4.3 Burn Infection
  2.4.4 Other Infections
2.5 Sulfonamides Market Size by Application
  2.5.1 Sulfonamides Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Sulfonamides Market Size Market Share by Application (2018-2023)

3 SULFONAMIDES MARKET SIZE BY PLAYER

3.1 Sulfonamides Market Size Market Share by Players
  3.1.1 Global Sulfonamides Revenue by Players (2018-2023)
  3.1.2 Global Sulfonamides Revenue Market Share by Players (2018-2023)
3.2 Global Sulfonamides Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SULFONAMIDES BY REGIONS

4.1 Sulfonamides Market Size by Regions (2018-2023)
4.2 Americas Sulfonamides Market Size Growth (2018-2023)
4.3 APAC Sulfonamides Market Size Growth (2018-2023)
4.4 Europe Sulfonamides Market Size Growth (2018-2023)
4.5 Middle East & Africa Sulfonamides Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Sulfonamides Market Size by Country (2018-2023)
5.2 Americas Sulfonamides Market Size by Type (2018-2023)
5.3 Americas Sulfonamides Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Sulfonamides Market Size by Region (2018-2023)
6.2 APAC Sulfonamides Market Size by Type (2018-2023)
6.3 APAC Sulfonamides Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Sulfonamides by Country (2018-2023)
7.2 Europe Sulfonamides Market Size by Type (2018-2023)
7.3 Europe Sulfonamides Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Sulfonamides by Region (2018-2023)
8.2 Middle East & Africa Sulfonamides Market Size by Type (2018-2023)
8.3 Middle East & Africa Sulfonamides Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SULFONAMIDES MARKET FORECAST

10.1 Global Sulfonamides Forecast by Regions (2024-2029)
  10.1.1 Global Sulfonamides Forecast by Regions (2024-2029)
  10.1.2 Americas Sulfonamides Forecast
  10.1.3 APAC Sulfonamides Forecast
  10.1.4 Europe Sulfonamides Forecast
  10.1.5 Middle East & Africa Sulfonamides Forecast
10.2 Americas Sulfonamides Forecast by Country (2024-2029)
  10.2.1 United States Sulfonamides Market Forecast
  10.2.2 Canada Sulfonamides Market Forecast
  10.2.3 Mexico Sulfonamides Market Forecast
  10.2.4 Brazil Sulfonamides Market Forecast
10.3 APAC Sulfonamides Forecast by Region (2024-2029)
  10.3.1 China Sulfonamides Market Forecast
  10.3.2 Japan Sulfonamides Market Forecast
  10.3.3 Korea Sulfonamides Market Forecast
  10.3.4 Southeast Asia Sulfonamides Market Forecast
  10.3.5 India Sulfonamides Market Forecast
  10.3.6 Australia Sulfonamides Market Forecast
10.4 Europe Sulfonamides Forecast by Country (2024-2029)
  10.4.1 Germany Sulfonamides Market Forecast
  10.4.2 France Sulfonamides Market Forecast
  10.4.3 UK Sulfonamides Market Forecast
  10.4.4 Italy Sulfonamides Market Forecast
  10.4.5 Russia Sulfonamides Market Forecast
10.5 Middle East & Africa Sulfonamides Forecast by Region (2024-2029)
  10.5.1 Egypt Sulfonamides Market Forecast
  10.5.2 South Africa Sulfonamides Market Forecast
  10.5.3 Israel Sulfonamides Market Forecast
  10.5.4 Turkey Sulfonamides Market Forecast
  10.5.5 GCC Countries Sulfonamides Market Forecast
10.6 Global Sulfonamides Forecast by Type (2024-2029)
10.7 Global Sulfonamides Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Sulfonamides Product Offered
  11.1.3 Pfizer Sulfonamides Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Sanofi
  11.2.1 Sanofi Company Information
  11.2.2 Sanofi Sulfonamides Product Offered
  11.2.3 Sanofi Sulfonamides Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Sanofi Main Business Overview
  11.2.5 Sanofi Latest Developments
11.3 Roche
  11.3.1 Roche Company Information
  11.3.2 Roche Sulfonamides Product Offered
  11.3.3 Roche Sulfonamides Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Roche Main Business Overview
  11.3.5 Roche Latest Developments
11.4 Mylan
  11.4.1 Mylan Company Information
  11.4.2 Mylan Sulfonamides Product Offered
  11.4.3 Mylan Sulfonamides Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Mylan Main Business Overview
  11.4.5 Mylan Latest Developments
11.5 Teva
  11.5.1 Teva Company Information
  11.5.2 Teva Sulfonamides Product Offered
  11.5.3 Teva Sulfonamides Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Teva Main Business Overview
  11.5.5 Teva Latest Developments
11.6 Bayer
  11.6.1 Bayer Company Information
  11.6.2 Bayer Sulfonamides Product Offered
  11.6.3 Bayer Sulfonamides Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Bayer Main Business Overview
  11.6.5 Bayer Latest Developments
11.7 Abbott
  11.7.1 Abbott Company Information
  11.7.2 Abbott Sulfonamides Product Offered
  11.7.3 Abbott Sulfonamides Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Abbott Main Business Overview
  11.7.5 Abbott Latest Developments
11.8 GlaxoSmithKline
  11.8.1 GlaxoSmithKline Company Information
  11.8.2 GlaxoSmithKline Sulfonamides Product Offered
  11.8.3 GlaxoSmithKline Sulfonamides Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 GlaxoSmithKline Main Business Overview
  11.8.5 GlaxoSmithKline Latest Developments
11.9 Boehringer Ingelheim
  11.9.1 Boehringer Ingelheim Company Information
  11.9.2 Boehringer Ingelheim Sulfonamides Product Offered
  11.9.3 Boehringer Ingelheim Sulfonamides Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Boehringer Ingelheim Main Business Overview
  11.9.5 Boehringer Ingelheim Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Sulfonamides Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Intestinal Absorption
Table 3. Major Players of Intestinal Tract Difficult to Absorb
Table 4. Major Players of External Use
Table 5. Sulfonamides Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Sulfonamides Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Sulfonamides Market Size Market Share by Type (2018-2023)
Table 8. Sulfonamides Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Sulfonamides Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Sulfonamides Market Size Market Share by Application (2018-2023)
Table 11. Global Sulfonamides Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Sulfonamides Revenue Market Share by Player (2018-2023)
Table 13. Sulfonamides Key Players Head office and Products Offered
Table 14. Sulfonamides Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Sulfonamides Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Sulfonamides Market Size Market Share by Regions (2018-2023)
Table 19. Global Sulfonamides Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Sulfonamides Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Sulfonamides Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Sulfonamides Market Size Market Share by Country (2018-2023)
Table 23. Americas Sulfonamides Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Sulfonamides Market Size Market Share by Type (2018-2023)
Table 25. Americas Sulfonamides Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Sulfonamides Market Size Market Share by Application (2018-2023)
Table 27. APAC Sulfonamides Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Sulfonamides Market Size Market Share by Region (2018-2023)
Table 29. APAC Sulfonamides Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Sulfonamides Market Size Market Share by Type (2018-2023)
Table 31. APAC Sulfonamides Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Sulfonamides Market Size Market Share by Application (2018-2023)
Table 33. Europe Sulfonamides Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Sulfonamides Market Size Market Share by Country (2018-2023)
Table 35. Europe Sulfonamides Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Sulfonamides Market Size Market Share by Type (2018-2023)
Table 37. Europe Sulfonamides Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Sulfonamides Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Sulfonamides Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Sulfonamides Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Sulfonamides Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Sulfonamides Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Sulfonamides Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Sulfonamides Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Sulfonamides
Table 46. Key Market Challenges & Risks of Sulfonamides
Table 47. Key Industry Trends of Sulfonamides
Table 48. Global Sulfonamides Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Sulfonamides Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Sulfonamides Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Sulfonamides Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Pfizer Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 53. Pfizer Sulfonamides Product Offered
Table 54. Pfizer Sulfonamides Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Sanofi Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 58. Sanofi Sulfonamides Product Offered
Table 59. Sanofi Main Business
Table 60. Sanofi Sulfonamides Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Sanofi Latest Developments
Table 62. Roche Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 63. Roche Sulfonamides Product Offered
Table 64. Roche Main Business
Table 65. Roche Sulfonamides Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Roche Latest Developments
Table 67. Mylan Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 68. Mylan Sulfonamides Product Offered
Table 69. Mylan Main Business
Table 70. Mylan Sulfonamides Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Mylan Latest Developments
Table 72. Teva Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 73. Teva Sulfonamides Product Offered
Table 74. Teva Main Business
Table 75. Teva Sulfonamides Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Teva Latest Developments
Table 77. Bayer Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 78. Bayer Sulfonamides Product Offered
Table 79. Bayer Main Business
Table 80. Bayer Sulfonamides Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Bayer Latest Developments
Table 82. Abbott Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 83. Abbott Sulfonamides Product Offered
Table 84. Abbott Main Business
Table 85. Abbott Sulfonamides Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Abbott Latest Developments
Table 87. GlaxoSmithKline Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 88. GlaxoSmithKline Sulfonamides Product Offered
Table 89. GlaxoSmithKline Main Business
Table 90. GlaxoSmithKline Sulfonamides Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. GlaxoSmithKline Latest Developments
Table 92. Boehringer Ingelheim Details, Company Type, Sulfonamides Area Served and Its Competitors
Table 93. Boehringer Ingelheim Sulfonamides Product Offered
Table 94. Boehringer Ingelheim Main Business
Table 95. Boehringer Ingelheim Sulfonamides Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Boehringer Ingelheim Latest Developments

LIST OF FIGURES

Figure 1. Sulfonamides Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sulfonamides Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Sulfonamides Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Sulfonamides Sales Market Share by Country/Region (2022)
Figure 8. Sulfonamides Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Sulfonamides Market Size Market Share by Type in 2022
Figure 10. Sulfonamides in Systemic Infection
Figure 11. Global Sulfonamides Market: Systemic Infection (2018-2023) & ($ Millions)
Figure 12. Sulfonamides in Intestinal Infection
Figure 13. Global Sulfonamides Market: Intestinal Infection (2018-2023) & ($ Millions)
Figure 14. Sulfonamides in Burn Infection
Figure 15. Global Sulfonamides Market: Burn Infection (2018-2023) & ($ Millions)
Figure 16. Sulfonamides in Other Infections
Figure 17. Global Sulfonamides Market: Other Infections (2018-2023) & ($ Millions)
Figure 18. Global Sulfonamides Market Size Market Share by Application in 2022
Figure 19. Global Sulfonamides Revenue Market Share by Player in 2022
Figure 20. Global Sulfonamides Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Sulfonamides Market Size 2018-2023 ($ Millions)
Figure 22. APAC Sulfonamides Market Size 2018-2023 ($ Millions)
Figure 23. Europe Sulfonamides Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Sulfonamides Market Size 2018-2023 ($ Millions)
Figure 25. Americas Sulfonamides Value Market Share by Country in 2022
Figure 26. United States Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Sulfonamides Market Size Market Share by Region in 2022
Figure 31. APAC Sulfonamides Market Size Market Share by Type in 2022
Figure 32. APAC Sulfonamides Market Size Market Share by Application in 2022
Figure 33. China Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Sulfonamides Market Size Market Share by Country in 2022
Figure 40. Europe Sulfonamides Market Size Market Share by Type (2018-2023)
Figure 41. Europe Sulfonamides Market Size Market Share by Application (2018-2023)
Figure 42. Germany Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Sulfonamides Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Sulfonamides Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Sulfonamides Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Sulfonamides Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 56. APAC Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 57. Europe Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 59. United States Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 60. Canada Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 63. China Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 64. Japan Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 65. Korea Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 67. India Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 68. Australia Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 69. Germany Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 70. France Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 71. UK Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 72. Italy Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 73. Russia Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 74. Spain Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 77. Israel Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Sulfonamides Market Size 2024-2029 ($ Millions)
Figure 80. Global Sulfonamides Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Sulfonamides Market Size Market Share Forecast by Application (2024-2029)


More Publications